Oncothyreon Inc (Nasdaq:ONTY) Remains Stable Following Strong ASCO Publications
[[tagnumber 0]][[tagnumber 1]]Unlike many other biotechs focused on finding novel cancer treatment solutions, the shares of Oncothyreon Inc (Nasdaq:ONTY) have been enjoying a somewhat more favourable chart performance following a couple of company–related publications...